Legalize Psilocybin Mushrooms

Poor mental health is the single largest cause of disability in the UK, and the wider economic costs of mental illness in England have been estimated at £105 billion each year, predominantly due to losses in productivity.

Some studies have found that psilocybin-assisted therapy for severe depression has long-term efficacy of more than 70%.

Removing psilocybin from Schedule 1 of the Misuse of Drugs Act 1971 could stimulate investment and innovation in research, trade, and healthcare.